IPO SnapShot

SHREE GANESH REMEDIES LTD.

IPODATE
Sep 28, 2017 TO Oct 05, 2017
LISTINGDATE
10/13/2017 12:00:00 AM
APPLY NOW
FACEVALUE
₹ 10

per share

ISSUESIZE
₹ 8.5536 Cr
PRICEBAND
₹ 36

per share

MARKETLOT
3000

shares

OBJECTIVE

OBJECTS OF THE ISSUEThe Issue comprises of fresh issue of 23,76,000 Equity Shares by our Company aggregating up to Rs.855.36 Lakhs (“Fresh Issue”).Our Company proposes to utilize the Net Proceeds from the issue towards the following objects:1. Setting up a new Choloro Compound derivatives manufacturing plant with a proposed capacity of200 MTPA at Ankleshwar GIDC Gujarat (“Project”) 2. General Corporate Purposes

DON'T HAVE A DEMAT ACCOUNT

OPENDEMAT ACCOUNTAND START YOURINVESTMENTJOURNEY WITH US

OPEN AN ACCOUNT (You will receive a call & SMS from our end)
BUSINESS DESCRIPTION

OVERVIEWOur Company was originally incorporated as “Shree Ganesh Remedies Private Limited” at Ahmedabad,Gujarat as a Private Limited Company under the provisions of Companies Act, 1956 vide Certificate ofIncorporation dated April 27, 1995 bearing registration number 025661 issued by Assistant Registrar ofCompanies, Gujarat, Dadra & Nagar Haveli. Subsequently, our Company was converted into...

ADDRESS

Address: Plot No. 6002
6003
6011 & 6012
G. I. D. C.
Bharuch
City: Ankleshwar,
State: Gujarat
Pincode: 393002
Phone: 07574 976076
Email: investors@ganeshremedies.com
Website: www.ganeshremedies.com

LISTED AT

BSE

LEAD MANAGER

Fedex Securities Ltd.

PROMOTERS

Ashokkumar Kothia
Babubhai Kothia
Chandubhai Kothia
Hansaben Kothia
Hasmukh Kothia
Manubhai Kothia
Subhash Kothia

PROMOTER'S HOLDING

Total Share Capital

5626398

Offered to Public

2376000

Promoter's Holding (Pre-Issue)

85.31

Promoter's Holding (Post-Issue)

62.72
REGISTRAR

Bigshare Services Pvt Ltd
G 10 Left Wing Amruta Village
Opp: Yashoda Hospital
Raj Bhavan Road
Somajiguda
Hyderabad

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.